Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
The global spread of HIV-1 subtype B epidemic.
Short Communication: Efficacy and Safety of Treatment Simplification to Lopinavir/Ritonavir or Darunavir/Ritonavir Monotherapy: A Randomized Clinical Trial.
Mutations Related to Antiretroviral Resistance Identified by Ultra-Deep Sequencing in HIV-1 Infected Children under Structured Interruptions of HAART.
Antiretroviral therapy suppressed participants with low CD4+ T-cell counts segregate according to opposite immunological phenotypes.
A Summary of the First HIV Microbiome Workshop 2015.
Virological failure to raltegravir in Spain: incidence, prevalence and clinical consequences.
Monotherapy with boosted PIs as an ART simplification strategy in clinical practice.
2015 Update of the Drug Resistance Mutations in HIV-1.
Determinants of virological failure and antiretroviral drug resistance in Mozambique.
Infection with human retroviruses other than HIV-1: HIV-2, HTLV-1, HTLV-2, HTLV-3 and HTLV-4.